Amble tirzepatide is a novel peptide-based medication that has shown significant potential in metabolic research. As a dual GIP and GLP-1 receptor agonist, amble tirzepatide offers unique mechanisms for studying weight management and glucose control.
The molecular structure of amble tirzepatide (C225H348N48O68) enables simultaneous activation of both GIP and GLP-1 receptors, making it particularly valuable for research into metabolic disorders. This white lyophilized powder maintains excellent stability when stored properly in cool, dry conditions.
Research suggests amble tirzepatide may help slow gastric emptying, reduce liver glucose production, and enhance pancreatic insulin secretion. These properties make it an important compound for studying type 2 diabetes and obesity-related metabolic pathways.
For laboratory use, amble tirzepatide is typically reconstituted with sterile water or buffer solution. Researchers should follow proper handling procedures and storage guidelines to maintain peptide integrity. The product is supplied in sealed vials to ensure maximum stability and purity.
Our manufacturing process ensures high purity amble tirzepatide with minimal related substances (≤0.5%) and low heavy metal content (≤20ppm). Each batch undergoes rigorous quality control testing to meet research standards.